Health Care • Medical/Dental Instruments
$252.83 ▲ +2.66
(+1.06%)
MKT CAP: $35.56B • VOL: 1.45M
52W L $180 52W H $278
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$212
MEDIAN
$283
MEAN
$288
HIGH
$344
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE RMD TAPE
RMD // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $305.92 | $290.75 | 2025-02-14 | $230.08 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $318.57 | $298.34 | 2025-02-06 | $237.66 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $288.23 | $278.11 | 2025-01-29 | $242.72 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $257.89 | — | 2025-01-17 | $247.77 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $222.49 | $240.19 | 2025-01-09 | $225.02 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $300.87 | $262.94 | 2024-12-18 | $219.96 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $245.25 | $255.36 | 2024-12-04 | $235.13 | -4.3% | 48% | C |